March 5, 2015 (GLOBE NEWSWIRE) Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it has submitted a Pre-Submission application to the FDA for its non-invasive Blood Volume Monitor, CM-1500. Zynex believes that this will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.
The NexWave incorporates IFC, TENS & NMES in one easy to use device. These three proven modalities have been used for over 30 years to help patients manage their pain symptoms & reduce or eliminate their need for pain medication.
The NexWaves unique 3-modalities-in-1-device is designed to break the pain cycle by:
- Managing symptomatic relief of chronic intractable pain, post traumatic and post-surgical pain
- Relaxing Muscle Spasms
- Increasing local blood circulation
- Maintaining or Increasing ROM
- Preventing or retarding disuse atrophy
- Re-educating muscles